Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets - PubMed (original) (raw)

Review

. 2007 Jul 31;581(19):3665-74.

doi: 10.1016/j.febslet.2007.04.033. Epub 2007 Apr 24.

Affiliations

Free article

Review

Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets

André-Patrick Arrigo et al. FEBS Lett. 2007.

Free article

Abstract

Hsp27 and alphaB-crystallin are molecular chaperones that are constitutively expressed in several mammalian cells, particularly in pathological conditions. These proteins share functions as diverse as protection against toxicity mediated by aberrantly folded proteins or oxidative-inflammation conditions. In addition, these proteins share anti-apoptotic properties and are tumorigenic when expressed in cancer cells. This review summarizes the current knowledge about Hsp27 and alphaB-crystallin and the implications, either positive or deleterious, of these proteins in pathologies such as neurodegenerative diseases, myopathies, asthma, cataracts and cancers. Approaches towards therapeutic strategies aimed at modulating the expression and/or the activities of Hsp27 and alphaB-crystallin are presented.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources